Collplant to participate in the upcoming 27th annual h.c. wainwright global investment conference

Rehovot, israel , aug. 25, 2025 /prnewswire/ -- collplant biotechnologies (nasdaq: clgn), a regenerative and aesthetics medicine company developing disruptive technologies and products based on its non-animal-derived recombinant human collagen (rhcollagen), today announced that senior management will participate in the upcoming 27th annual h.c. wainwright global investment conference on monday, september 8 th and tuesday september 9 th, 2025, at the lotte new york palace hotel.
CLGN Ratings Summary
CLGN Quant Ranking